Literature DB >> 31452070

A rare case of pituitary oncocytoma successfully treated with single-fraction stereotactic Gamma Knife surgery.

Constantin Tuleasca1,2,3,4,5, Roy Thomas Daniel6,7, Marc Levivier6,7.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31452070     DOI： 10.1007/s11060-019-03270-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  5 in total

1.  Gamma Knife radiosurgery for cervical spine lesions: expanding the indications in the new era of Icon.

Authors:  Constantin Tuleasca; Henri-Arthur Leroy; Jean Régis; Marc Levivier
Journal:  Acta Neurochir (Wien)       Date:  2016-09-23       Impact factor: 2.216

2.  Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study.

Authors:  Jason P Sheehan; Robert M Starke; David Mathieu; Byron Young; Penny K Sneed; Veronica L Chiang; John Y K Lee; Hideyuki Kano; Kyung-Jae Park; Ajay Niranjan; Douglas Kondziolka; Gene H Barnett; Stephen Rush; John G Golfinos; L Dade Lunsford
Journal:  J Neurosurg       Date:  2013-04-26       Impact factor: 5.115

3.  Hypopituitarism After Single-Fraction Pituitary Adenoma Radiosurgery: Dosimetric Analysis Based on Patients Treated Using Contemporary Techniques.

Authors:  Christopher S Graffeo; Michael J Link; Paul D Brown; William F Young; Bruce E Pollock
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-03-08       Impact factor: 7.038

4.  Long-term evaluation of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery.

Authors:  Jacqueline A Leavitt; Scott L Stafford; Michael J Link; Bruce E Pollock
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-11-01       Impact factor: 7.038

5.  Single-fraction stereotactic radiosurgery for spindle cell oncocytoma: preliminary experience and systematic review of the literature.

Authors:  Soliman Oushy; Christopher S Graffeo; Avital Perry; Scott L Stafford; Michael J Link; Bruce E Pollock
Journal:  J Neurooncol       Date:  2019-06-28       Impact factor: 4.130
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.